UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.90 -0.73 (-0.88%) GOLD FUTURES
2,306.70 -51.00 (-2.16%) DOW
38,039.26 -346.83 (-0.90%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
NVO Jan 2025 130.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:43AM EDT. Market open.
| Previous close | 13.30 |
| Open | 13.00 |
| Bid | 12.45 |
| Ask | 12.80 |
| Strike | 130.00 |
| Expiry date | 2025-01-17 |
| Day's range | 13.00 - 13.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 356 |
Yahoo FinanceEli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
Investor's Business DailyIBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Eli Lilly stock jumped Tuesday despite a mixed first-quarter report, after sales of weight-loss drug Zepbound obliterated expectations.
ZacksEli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Eli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.
© 2024 Yahoo. All rights reserved.